Brain wave test may personalize thinking skills training for veterans
NCT ID NCT04395157
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a brain wave measurement called mismatch negativity (MMN) can help match veterans with mental illness to the most effective cognitive training program. 100 veterans with conditions like schizophrenia, PTSD, or mood disorders participated. The goal was to see if this approach improves thinking, daily function, and quality of life better than a one-size-fits-all method.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- computerized cognitive training exercises
- What this could lead to
- If successful, this could help personalize cognitive rehabilitation for veterans with mental illness, improving thinking skills and daily life.
- What could go wrong
- This is a small, completed study focused on matching people to treatment, not testing a new therapy. Results may not apply broadly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
VA San Diego Healthcare System, San Diego, CA
San Diego, California, 92161-0002, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill for schizophrenia pass its first human test?
- Can a structured care pathway ease teen depression?
- Can a nasal spray break through tough depression?
- Could a new drug offer hope for Treatment-Resistant depression?
- Can a new pill quiet the mind? a large trial puts it to the test
- Can a new daily pill offer safer Long-Term control of schizophrenia?